FDA Takes Action against Unapproved Cold Meds

The FDA initiated a big move on March 2 to help ensure patient safety. The agency called for the stop of sales of about 500 unapproved prescription allergy, cold, and cough medicines--some of which are extended-release drugs.

Some of the affected treatments, according to the FDA, include Aerohist extended-release tablets, Aquatab DM tablets extended release, and Certuss multilayer extended release tablets. Other impacted medicines, including Lodrane 24 D, are unapproved combinations of drugs.